June 22 (Reuters) – Antengene Corp Ltd: * ENTERS EXCLUSIVE LICENSE AGREEMENT WITH K2 THERAPEUTICS FOR ATG-106 * TO RECEIVE ABOUT $20 MILLION UPFRONT AND NEAR-TERM CONSIDERATION Further company
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Braves claim seventh NL East title in nine seasons with win over Astros
VIDEO SHOWS: HIGHLIGHTS OF THE MLB GAME BETWEEN THE ATLANTA BRAVES AND THE HOUSTON ASTROS…
GRAPHIC-Take Five: High stakes, low bars
(Repeats item that ran on Friday with no changes) Sept 21 (Reuters) - World markets…
Humanoid robot sales tally hit 7,000 globally last year
By Toby Sterling AMSTERDAM, Sept 21 (Reuters) - Around 7,000 humanoid robots were sold worldwide…
